# Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus

> **NCT00145093** · PHASE3 · COMPLETED · sponsor: **Medical Research Foundation, The Netherlands** · enrollment: 60 (—)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Baker's yeast (Bio Chromium)

## Key facts

- **NCT ID:** NCT00145093
- **Lead sponsor:** Medical Research Foundation, The Netherlands
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 60 (—)
- **Last updated:** 2005-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145093, "Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00145093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*